Document is current
Any future updates will be listed below
-
Authors
Ajoolabady, Amir http://orcid.org/0000-0002-3667-2605
Tang, Daolin http://orcid.org/0000-0002-1903-6180
Kroemer, Guido
Ren, Jun http://orcid.org/0000-0002-0275-0783
- License Information
-
More Information
Article History
Received: 29 April 2022
Revised: 25 August 2022
Accepted: 22 September 2022
First Online: 13 October 2022
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: GK has been holding research contracts with Daiichi Sankyo, Eleor, Kaleido, Lytix Pharma, PharmaMar, Samsara, Sanofi, Sotio, Tollys, Vascage and Vasculox/Tioma. GK has been consulting for Reithera. GK is on the Board of Directors of the Bristol Myers Squibb Foundation France. GK is a scientific co-founder of everImmune, Osasuna Therapeutics, Samsara Therapeutics and Therafast Bio. GK is the inventor of patents covering therapeutic targeting of ageing, cancer, cystic fibrosis and metabolic disorders. The remaining authors declare no competing interests.
